-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on XPLR Infr, Lowers Price Target to $6

Benzinga·04/17/2025 14:51:22
Listen to the news
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $7 to $6.